New Histoplasma Diagnostic Assays Designed via Whole Genome Comparisons

Juan E Gallo1,2,3, Isaura Torres1,3, Oscar M Gómez1,3

  • 1Cellular and Molecular Biology Unit, Corporación para Investigaciones Biológicas (CIB), Medellín 05534, Colombia.

Insights

New PCR assays targeting Histoplasma DNA offer a faster and more accurate diagnosis for histoplasmosis. These novel primer sets demonstrate high specificity and sensitivity, potentially improving patient outcomes and reducing diagnostic delays.

Area of Science:

  • Medical Mycology
  • Molecular Diagnostics
  • Infectious Diseases

Background:

  • Histoplasmosis, a systemic fungal infection caused by Histoplasma spp., leads to significant illness and death, particularly in individuals with HIV/AIDS.
  • Current diagnostic methods, primarily culture-based, are time-consuming, often taking weeks for results.
  • Existing molecular assays lack standardization and comprehensive validation.

Purpose of the Study:

  • To develop and validate novel PCR (polymerase chain reaction) assays for the rapid and accurate detection of Histoplasma.
  • To identify and utilize unique Histoplasma genomic sequences for primer design.
  • To establish a proof of principle for rationally designing standardized molecular diagnostic assays for fungal pathogens.

Main Methods:

  • Bioinformatic analysis of aligned genome sequences to identify genus-specific genes.
  • Design and synthesis of primer sets targeting the identified PPK and CFP4 genes.
  • Development of conventional and real-time PCR assays.
  • In vitro analytical specificity and sensitivity testing using purified DNA and clinical samples (FFPE).

Main Results:

  • Two novel primer sets targeting PPK and CFP4 genes were successfully designed.
  • Both primer sets exhibited 100% analytical specificity in vitro.
  • The assays accurately detected all 62 tested Histoplasma capsulatum isolates and 2 clinical FFPE samples.
  • Analytical sensitivity was confirmed through serial dilutions of control plasmids.

Conclusions:

  • The developed primer sets enable sensitive and specific detection of Histoplasma, reducing the risk of false positives and cross-reactions.
  • These novel assays represent a significant advancement over traditional culture methods, offering faster diagnosis.
  • The rational design approach can be applied to develop affordable and simple molecular assays for other pathogenic fungi.